{"schema":"sb.node.v1","id":"sb:e/72184507869666735f1fe0c4","kind":"entity","label":{"text":"pancreatic cancer","locale":"en"},"identity":{"anchor":"label:en:pancreatic cancer","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-06T19:01:48.073148+00:00","snapshot":"deploy 5dfee874e7fefec07fed541777335b2d587f80c6"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":140,"separatePublishers":67,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim"},"admission":{"state":"canonical","reason":"entity graph provenance 'curated'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-01-01","to":"2026-10-06","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.157: about 84% of mentions carry no typed assertion"]}},"dimensions":{"domains":["oncology","pubmed_targeted"],"activeDays":65,"assertions":{}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":12,"byKind":{"observation":12},"items":[{"id":"sb:o/83ccaf5cc08c13fefda26d8c","kind":"observation","label":"Latest Science News -- ScienceDaily · 2026-10-04 · Vitamin D drug may help crack pancreatic cancer’s protective shield","url":"https://www.sciencedaily.com/releases/2026/09/260930225501.htm"},{"id":"sb:o/cda68156c6853c8762540eb3","kind":"observation","label":"The Clinical Trial Vanguard · 2026-10-01 · The VIRAGE Trial Cracked the Pancreatic Cancer Wall. Now the Hard Question Is Whether the Field Can Read the Blueprint.","url":"https://www.clinicaltrialvanguard.com/opinion/the-virage-trial-cracked-the-pancreatic-cancer-wall-now-the-hard-question-is-whether-the-field-can-read-the-blueprint/"},{"id":"sb:o/fab6f4dc67f993a2cce58eb1","kind":"observation","label":"Nature Medicine · 2026-09-30 · Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial","url":"https://www.nature.com/articles/s41591-026-04705-y"},{"id":"sb:o/76398f80f5bf13e7cc55a4f3","kind":"observation","label":"Medical Daily · 2026-09-30 · Five Radiation Sessions Before Pancreatic Cancer Surgery Preserved Physical Function, but Survival Was Numerically Lower in Small Trial","url":"https://www.medicaldaily.com/sbrt-pancreatic-cancer-surgery-physical-function-survival-astro-2026-479290"},{"id":"sb:o/cdaf58b3ecbddad70977fce9","kind":"observation","label":"Expert Opin Biol Ther · 2026-09-28 · Harnessing novel agents to target KRAS-driven pathways in pancreatic cancer.","url":"https://doi.org/10.1080/14712598.2026.2738708"},{"id":"sb:o/2125d21e0b30442f50e0317e","kind":"observation","label":"The Clinical Trial Vanguard · 2026-09-26 · Annamycin Shows Immune Activation in Pancreatic Cancer Preclinical Study","url":"https://www.clinicaltrialvanguard.com/news/annamycin-shows-immune-activation-in-pancreatic-cancer-preclinical-study/"},{"id":"sb:o/e91f4059f380b1e642106d32","kind":"observation","label":"European Medical Journal · 2026-09-25 · Pancreatic Cancer Mortality Remains Unequal Across Japan","url":"https://www.emjreviews.com/oncology/news/pancreatic-cancer-mortality-remains-unequal-across-japan/"},{"id":"sb:o/0544879d180edb13adb21590","kind":"observation","label":"bioRxiv Cancer Biology · 2026-09-25 · Context-specific genetic interaction mapping reveals combinatorial KRAS/FGFR dependence in pancreatic cancer","url":"https://www.biorxiv.org/content/10.64898/2026.09.24.754062v1?rss=1"},{"id":"sb:o/d36fa9b95d05d1d22b0da0cc","kind":"observation","label":"Inside Precision Medicine · 2026-09-24 · New Immunotherapy Strategy Extends KRAS Inhibitor Response in Pancreatic Cancer","url":"https://www.insideprecisionmedicine.com/topics/oncology/new-immunotherapy-strategy-extends-kras-inhibitor-response-in-pancreatic-cancer/"},{"id":"sb:o/e5a396470aa183f1936cba20","kind":"observation","label":"GEN - Genetic Engineering & Biotechnology News · 2026-09-24 · Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models","url":"https://www.genengnews.com/topics/cancer/genialis-and-inventia-life-science-collaborate-to-link-patient-biology-with-3d-pancreatic-cancer-models/"}],"cursor":"c1.eyJpZCI6InNiOmUvNzIxODQ1MDc4Njk2NjY3MzVmMWZlMGM0IiwibCI6ImNoaWxkcmVuIiwibyI6MTAsImsiOm51bGwsImEiOiIyMDI2LTEwLTA2VDE5OjAxOjQ4LjA3MzE0OCswMDowMCJ9","order":"newest first; we keep the 12 newest receipts for this entity. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":10,"byKind":{"co-mentioned":10},"items":[{"kind":"relation","label":"co-mentioned with kras (60 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/83d1c9a39c2982651db49395"},{"kind":"relation","label":"co-mentioned with fda (33 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/5f1f3d528cc1d341f3b1e75b"},{"kind":"relation","label":"co-mentioned with immunotherapy (28 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/91c323b5f9c72172c5e7f76a"},{"kind":"relation","label":"co-mentioned with clinical trial (26 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/13c0fbf0d4262b471b87c63b"},{"kind":"relation","label":"co-mentioned with colorectal cancer (23 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/b3f4dd19d76675037d0043e6"},{"kind":"relation","label":"co-mentioned with pdac (20 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/c5e1c60f3bc6a641dffac603"},{"kind":"relation","label":"co-mentioned with ai (20 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/a55f3e83bc5fa22407969f4a"},{"kind":"relation","label":"co-mentioned with lung cancer (19 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/5d72963647a2ba2d59313a30"},{"kind":"relation","label":"co-mentioned with breast cancer (18 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/45857007e55d0611c12c68f6"},{"kind":"relation","label":"co-mentioned with ctdna (14 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/0fb7bbacda081ac34757b0f7"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/72184507869666735f1fe0c4","mcp":"traverse {\"id\":\"sb:e/72184507869666735f1fe0c4\"}","page":"/entity/pancreatic-cancer/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/72184507869666735f1fe0c4\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/72184507869666735f1fe0c4\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/72184507869666735f1fe0c4\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/72184507869666735f1fe0c4\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}